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Glutaraldehyde is a well-known substance used in biomedical research to fix cells. Since
hemolytic anemias are often associated with red blood cell shape changes deviating
from the biconcave disk shape, conservation of these shapes for imaging in general
and 3D-imaging in particular, like confocal microscopy, scanning electron microscopy
or scanning probe microscopy is a common desire. Along with the fixation comes an
increase in the stiffness of the cells. In the context of red blood cells this increased rigidity
is often used to mimic malaria infected red blood cells because they are also stiffer than
healthy red blood cells. However, the use of glutaraldehyde is associated with numerous
pitfalls: (i) while the increase in rigidity by an application of increasing concentrations of
glutaraldehyde is an analog process, the fixation is a rather digital event (all or none); (ii)
addition of glutaraldehyde massively changes osmolality in a concentration dependent
manner and hence cell shapes can be distorted; (iii) glutaraldehyde batches differ in
their properties especially in the ratio of monomers and polymers; (iv) handling pitfalls,
like inducing shear artifacts of red blood cell shapes or cell density changes that needs
to be considered, e.g., when working with cells in flow; (v) staining glutaraldehyde
treated red blood cells need different approaches compared to living cells, for instance,
because glutaraldehyde itself induces a strong fluorescence. Within this paper we
provide documentation about the subtle use of glutaraldehyde on healthy and pathologic
red blood cells and how to deal with or circumvent pitfalls.
Keywords: glutaraldehyde, erythrocytes, hemolytic anemia, fixation, cell shapes, stiffness, osmolality,
batch variation
INTRODUCTION
Besides its application as disinfectant and medication, glutaraldehyde is used in biomedical research
to fix cells. The principle behind the fixation is the binding of glutaraldehyde to nucleophiles of
which the amino groups are the most abundant but binding to, e.g., sulfhydryl groups also occurs
(Griffiths, 1993). The result is a crosslinking of the proteins of the cell (Kawahara et al., 1997),
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Figure 1. Approximately 45–50 years ago, glutaraldehyde
and its properties were a hot research topic (Richards and
Knowles, 1968; Hardy et al., 1969; Robertson and Schultz,
1970; Morel et al., 1971; Gillett and Gull, 1972; Rasmussen
and Albrechtsen, 1974; Squier et al., 1976). Such studies
mention the abundance of this molecule in monomeric and
polymeric form, discussing the formation of polymers at high
temperatures and arguing the influence of monomers and
polymers in fixation efficiency. Nowadays glutaraldehyde is
“only” used as a tool to fix cells. Especially for rare red
blood cell (RBC)-related diseases, cell shape is an important
diagnostic parameter and fixation is an approach to circumvent
the subtle sample transportation challenge (Makhro et al.,
2016; Hertz et al., 2017). However, a large variety of protocols
exist due to laboratory specific customs and habits. Even for
the storage of the glutaraldehyde a non-representative poll
among collaborators revealed storage from room temperature,
refrigerated to frozen conditions.
Along with the fixation comes an increase in the stiffness
of the cells. In the context of RBCs this increased rigidity is
often used to mimic malaria infected RBCs because they are also
stiffer than healthy RBCs (Aingaran et al., 2012). Furthermore,
hydrodynamic studies on blood flow and RBC interactions
use glutaraldehyde as a parameter to change cellular rigidity,
supposing a gradual concentration dependent process increases
the stiffness of the cells.
Here we summarize properties and provide original data of
glutaraldehyde’s action on RBCs and stress the parameters that
are important in particular in respect to RBC related pathologies
FIGURE 1 | The structure of glutaraldehyde. (A) The molecular structure of
glutaraldehyde in non-concentrated aqueous solution and the possible
conversion paths. (B) The principal structure of glutaraldehyde in aqueous
solution in the current theory in biochemistry. This figure is a reprint from
Kawahara et al. (1997).
to avoid pitfalls and to allow data reproducibility as well as
interlaboratory-comparability.
MATERIALS AND METHODS
Blood Collection
Donors and patients were enrolled in the study after signing
an informed consent. The procedure is approved by the local
ethics committee (approval no. 51/18) and was performed in
accordance with the Helsinki international ethical standards on
human experimentation. Venous blood was collected into EDTA
coated tubes (1.6 mg/ml). RBCs were isolated from the whole
blood by washing (centrifugation, 380 × g, 5 min) 3 times with
PBS (Sigma, Germany).
Glutaraldehyde Supply
Partly because this paper reflects a collaborative project including
partners at different locations and partly by purpose, different
sources of glutaraldehyde have been used throughout this study.
The source (supplier), the mode of storage and in which
experiments/measurements they were used in are summarized
in Table 1.
RBC Stability Test
PBS solutions (39.4 ml) with various concentrations of
glutaraldehyde (various suppliers) were prepared in 50 ml tubes.
Packed RBCs (600 µl) were pipetted slowly into the solution.
The large tube and the high solution/cell volume ratio (65:1) was
chosen to make sure the sample had sufficient volume to fix as
individual cells and would not form aggregates. The tubes were
placed on a tube roller for 1 h to allow for glutaraldehyde to
fix. After the fixation procedure, glutaraldehyde was removed by
washing the cells 3 times with PBS and resuspended in the same
solution. To test the “stability” of the cells the supernatant was
spectroscopically tested for hemoglobin to identify the portion of
lysed cells. For the spectrophotometry each tube was resuspended
completely until the whole sample appeared homogenous. Three
milliliter from each sample were placed into a new tube and
centrifuged at 500 × g for 5 min to get a clear distinction
between the pellet and the supernatant. One milliliter from the
supernatant was placed in a spectrometer cuvette and was diluted
1:3 with PBS to ensure the hemoglobin absorption value is within
the limits of the spectrophotometer (Red Tide, Ocean Optics,
Netherlands). The hemoglobin absorption peak of the Soret
band at about 420 nm was observed and compared between the
samples. As a 100% hemolysis reference, healthy RBCs were lysed
with distilled water to measure the total hemoglobin content.
Spectroscopy
To determine the ratio of glutaraldehyde monomers and
polymers, UV-absorption spectroscopy was performed at
room temperature. The extinction peaks are at 280 nm for
monomers and at around 235 nm for polymers (Morel et al.,
1971). To determine the monomer-polymer ratio, putative 1%
glutaraldehyde samples were prepared in water. Spectra were
recorded on these samples for wavelengths from 200 nm to
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TABLE 1 | Sources of glutaraldehyde and in which measurements they were used.
Supplier and grade Mode of storage Measurements used
Sigma, grade I, 25% in H2O −20◦C; more than one year of storage, thawed for every use Figures 2A,C; batch 1 in Figures 3B, 4B,C
Merck 25% in H2O Refrigerated Figure 2B
Sigma, grade I, 25% in H2O −20◦C; fresh batch Figures 3A,C, 5, 6B,D, 7B, 8; batch 2 in Figures 3B,
4B,C; dashed line in Figure 4A; bold lines in Figure 6A
Merck 25% in H2O room temperature for more than one year batch 3 in Figures 3B, 4B,C; solid line in Figure 4A
Sigma, grade I, 50% in H2O −20◦C, aliquoted upon delivery batch 4 in Figures 4B,C; thin lines in Figure 6A
Fluka 25% in H2O room temperature for more than one year Figures 7A, 9
350 nm on Thermo Scientific Evolution 220 (Thermo Fisher,
United States). To measure trypan blue’s absorption spectra,
0.01% trypan blue (Sigma-Aldrich, United States) solution was
prepared in PBS and recorded for wavelengths from 200 to
750 nm. The hemoglobin absorption spectrum was measured as
detailed before (Kaestner et al., 2006).
The emission and excitation spectra of the glutaraldehyde
induced fluorescence was measured with a Jasco FP-6500
spectrofluorometer (Jasco, Germany). RBCs were fixed with 1%
glutaraldehyde from different batches for one hour, washed three
times in PBS and resuspended in PBS to the concentration of
0.01125% to avoid excessive scattering. For the emission spectra
measurements, excitation was set to 450 nm and the fluorescence
was recorded in the range from 480 nm to 750 nm. For the
excitation spectra, emission was set to 540 nm and the excitation
scanned from 350 nm to 500 nm.
Elongation Index
To compare the mechanical properties of RBCs treated with
various concentrations of glutaraldehyde, their elongation index
was measured by LoRRca Maxsis (Mechatronics, Netherlands).
Samples were treated as outlined above (2.2 RBC stability test).
For each case 25 µl of 45% cell suspension in PBS were mixed
with 5 ml of polyvinylpyrrolidone buffer (PVP, Mechatronics,
Netherlands). The range of set shear was 1 to 30 Pa.
Atomic Force Spectroscopy
In order to investigate the variation between cells at certain
concentrations of glutaraldehyde, atomic force microscopy
(AFM) was employed. All measurements were performed in
PBS with the JPK Nanowizard 3 (Bruker, Germany) setup
coupled with a microscope. Effective Young’s modulus of cells
was measured through force-distance curves. The variety of
cantilevers of MLCT model (Bruker AFM Probes, United States)
with different nominal spring constants as well as different
indentation forces were tested in order to adapt measurement
conditions for each glutaraldehyde concentration. Prior to the
measurements cells were immobilized on the substrate with Cell-
Tak (Corning, United States). Force mapping was performed
for 3–5 cells of each population on a grid of 32 × 32 points,
corresponding to a 10 µm × 10 µm map. Force-distance curves
were acquired at the indentation rate of 5 µm/s. Curves were
analyzed according to the Hertz model, implemented in the JPK
software. The Poisson ratio was set to 0.5.
Measurement of Osmolality
Glutaraldehyde was added to PBS for osmolality measurements.
The osmometer (Type 6, Loser Messtechnik, Germany) was
checked for zero display with distilled water prior to each
measurement. Glutaraldehyde solutions in PBS with various
concentrations were diluted 1:10 to have a 110 µl sample.
Density Measurements
The densities of glutaraldehyde treated cells were determined by
adjusting the density of solutions they were suspended in. In an
Eppendorf tube with treated cells, the percentage of OptiPrep
(Stemcell Technologies, Canada) was adjusted slowly to match
the density of treated cells. To determine the cell density values,
tubes with known concentration of OptiPrep were centrifuged
at 500 × g. In the case where the density of the solution
matched the density of the cells, no sedimentation was observed
after centrifugation.
Sample Preparation for Microscopy
Ten microliters of blood were diluted 1 to 10 in PBS and
directly added to 1 ml of 1% or 0.1% glutaraldehyde in
PBS. Additional samples were prepared in order to study
the stability of RBCs shapes within the spherocyte-discocyte-
echinocyte scale in fixative solutions. The samples were prepared
by suspending 30 µl of whole blood in 1 ml NaCl solutions
with different osmolality. A hypotonic solution (131 mosmol/kg
H2O) was used to form spherocytes, a hypertonic solution
(800 mosmol/kg H2O) for echinocytes and an isotonic solution
(290 mosmol/kg H2O) was used for discocytes. After inducing the
shape transformations, 20 µl of each cell suspension were fixed
in 1 ml of the respective NaCl solutions supplemented with 1%
or 0.1% glutaraldehyde. Since the addition of 1% glutaraldehyde
increases the osmolality of the solutions, extra samples were fixed
in respective NaCl solutions that were diluted in order to keep
the same final osmolality after addition of 1% glutaraldehyde.
Samples were kept in rotation (Grantbio, United Kingdom) for
1 h at room temperature. Consequently, cells were washed three
times by addition of 1 ml of each respective original solution and
centrifuged at 735 × g for 3 min. Finally, cells were resuspended
in 1 ml of their original solution. Brightfield images of both live
Frontiers in Physiology | www.frontiersin.org 3 May 2019 | Volume 10 | Article 514
fphys-10-00514 May 10, 2019 Time: 14:45 # 4
Abay et al. Glutaraldehyde for Preservation of Erythrocytes
and fixed cells were acquired with a 50× objective (LU Plan
50×, NA = 0.55) on an inverted microscope (Eclipse TE2000-
S, Nikon, Japan).
Staining Procedures
Eosin-5′-maleimide (EMA) membrane staining was performed
on both fresh and glutaraldehyde fixed RBCs. Two microliters
of blood were added to 50 µl EMA (5 mg/ml) supplemented
with 10 mM CaCl2 and incubated at room temperature for
2 hours in rotation (Suemori et al., 2015). Samples were washed
3 times with 1 ml of Tyrode solution, containing in mM:
135 NaCl, 5.4 KCl, 5 glucose, 1 MgCl2, 1.5 CaCl2 and 10
HEPES, pH 7.4, each time spun at 300 × g for 2 min. Cells
were resuspended in 1 ml of Tyrode solution and imaged in
confocal microscopy with a 100x oil objective (Plan Apo TIRF,
NA = 1.49, Nikon, Japan) and an excitation wavelength of
488 nm. Glutaraldehyde induced fluorescence was examined at
an excitation wavelength of 647 nm.
Some of the samples were fluorescently labeled for 3D
image acquisition with confocal microscopy. Staining of
the cell membrane was performed either with CellMaskTM
Deep Red (Life Technologies, United States) or with PKH67
(Sigma-Aldrich, United States). Living cells were stained for
comparison with fixed samples. CellMask staining was performed
by adding 1 µl of CellMask stock solution (0.5 µg/ml) into
the RBCs suspension followed by incubation for 5 min and 3
washes prior to resuspension in 1 ml PBS. For PKH67, 10 µl of
packed cells were stained with 0.5 µl PKH67 as recommended
by the manufacturer and incubated at room temperature for
5 min. 3 washes followed before resuspension in 1 ml PBS.
Living cells were resuspended in PBS supplemented with 0.1%
bovine serum albumin.
Flow Cytometry
Fixed cells were used for immunofluorescence tests performed
by flow cytometry on cord blood to measure fetal hemoglobin
(HbF) content. Ten microliters of whole cord blood were
fixed for 10 min in either 0.05% or 1% glutaraldehyde in
PBS. An appropriate staining buffer suggested by the company
(BD Biosciences, United States) was used for next steps. After
one wash, cells were permeabilized with 0.1% Triton X-100
(Sigma-Aldrich, United States) solution for 10 min. Cells were
then washed and incubated with FITC mouse anti-human
fetal hemoglobin antibody (BD Biosciences, United States) for
20 min at room temperature. After washes, cells were finally
resuspended in 500 µl of staining buffer and 100,000 events
were recorded by flow cytometry (Gallios Flow Cytometer,
Beckman Coulter, United States). Each stained sample was
measured together with its respective unstained fixed sample
used as a negative control. Living cells were also analyzed for
comparison. Plots were obtained with the software FlowJo V10
(BD Biosciences, United States).
3D Imaging
Cells were placed between two glass cover slips (24 mm× 60 mm)
with a suspension of beads with a 20 µm diameter used as
spacers between the cover slips. A 60× oil objective (CFI
Plan Apochromat Lambda 60× Oil, NA = 1.4) of an inverted
microscope (Eclipse Ti, Nikon, Japan) was used to image. Cells
were scanned using a diode laser emitting at 647 nm (LU-NV
Laser Unit, Nikon, Japan) in a z-range of 20 µm with steps
of 300 nm. A spinning disk-based confocal head (CSU-W1,
Yokogawa Electric Corporation, Japan) was used to generate the
images. 3D reconstruction was later performed with a Matlab
R2017b (MathWorks, United States) routine.
Examination of Autofluorescence
Quenching
To test the quenching of glutaraldehyde autofluorescence, fixed
cells were permeabilized with 1 ml 0.1% Triton X-100 for 10 min,
washed and resuspended in 1 ml PBS. Two hundred microliter of
cell suspension were added to 800 µl of 0.4% trypan blue (Sigma-
Aldrich, United States) in PBS. After 15 min of incubation
at room temperature, cells were washed twice and imaged as
described before.
Scanning Electron Microscopy (SEM)
Fixed samples in 1% glutaraldehyde solution (Fluka, Germany)
were centrifuged on circular glass coverslips (10 mm, Schott,
Germany) for 6 min at 40 × g in a cytocentrifuge (Cytospin
2 SHANDON, United States). Sample slides were immediately
resuspended in PBS to avoid sample drying and washed 3 times
to remove any glutaraldehyde residues. Post fixation was done
for 30 min in a solution containing 1% osmium tetroxide in
PBS, followed by 3 washes in PBS, 5 min each. Samples were
dehydrated in increasing ethanol concentrations: 30 min in 70%
ethanol, 30 min in 80% ethanol and overnight in 100% ethanol.
Cells were dried in a critical point drying (Bal-tec CPD030,
United States), mounted on aluminum stubs and sputter coated
with 4 nm platinum (Safematic CCU-010, Switzerland). SEM
(Zeiss Supra 50 VP, Germany) imaging was performed at 10 kV
with a secondary electron detector for a 5000×magnification.
RESULTS
Fixation vs. Modulation of Stiffness
The protocols so far published are confusing concerning the
application of the glutaraldehyde concentration because they
range from 0.0005% to 8% (Morel et al., 1971; Tong and Caldwell,
1995; Guo et al., 2014) and all use the term “to fix cells” upon the
application of glutaraldehyde.
Basing on the assumption that fixed cells may be conserved for
a long time (ideally months or even years) with no morphological
changes or lysis of the cells, we investigated the shelf life
by treating samples with various glutaraldehyde concentrations
kept at 4◦C for 6 days. Every 2 days the supernatant sample
was prepared to measure the free hemoglobin content in the
suspensions. It correlates directly to the amount of lysed cells
in the samples. Figure 2A reveals glutaraldehyde’s seemingly
digital (all or none) fixation property. Percentages above 0.01%
showed almost no hemoglobin in the supernatant. At lower
concentrations, increase in glutaraldehyde percentage increase
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FIGURE 2 | Dependence of fixation and rigidity on the glutaraldehyde
concentration. (A) Hemolysis of RBC in suspension without and with the
specified concentrations of glutaraldehyde 2, 4 and 6 days after
withdrawal/initial treatment. Living RBCs (leftmost columns) show an
increased hemolysis over time which is further increased with increasing
glutaraldehyde concentrations (0.0001 and 0.001%) until the cells reach a
fixed state (0.01% to 1% glutaraldehyde). (B) Measurements of the elongation
index for living RBCs vs. populations treated with 0.0001, 0.001, 0.01, 0.1,
and 1% glutaraldehyde. (C) Histograms for the determination of the elastic
modules of living RBCs vs. their treatment with 0.001 and 0.0025%
glutaraldehyde. Please note that the histograms partly overlap, e.g., the
brown appearing columns represent the overlap of the orange and gray
columns. The inset are illustrate the AFM measurements. The images show a
RBC fixed with 0.0025% glutaraldehyde. The color code of the left image
depicts the height/thickness of the cell, while the right image represents
slopes of force-displacement curves. Scale bars indicate 5 µm. Please note
that the indicated glutaraldehyde concentrations in all panels are
batch-specific and not of general validity.
the hemolysis rate compared to unfixed control cells until
glutaraldehyde reaches a concentration were RBCs are fixed.
To probe the stiffness of glutaraldehyde-treated RBCs we used
an ektacytometer, LoRRca, a routine tool to investigate hemolytic
anemias (Zaninoni et al., 2018). Figure 2B reveals that very
low concentrations of glutaraldehyde (here: 0.0001%) resemble
the mechanical behavior of living cells, while concentrations
above 0.01% glutaraldehyde are (in agreement with Figure 2A)
indistinguishable in their elongation index plot. Interestingly,
0.001% glutaraldehyde shows indeed a curve/behavior in between
the two extreme conditions. Using atomic force spectroscopy,
we had a closer look in the latter range and compared living
RBCs with 0.001 and 0.0025% glutaraldehyde treated RBCs
(Figure 2C). On the one hand this plot shows that indeed the
cell populations are shifted in their elastic module in dependence
of the glutaraldehyde concentration. On the other hand, one can
also notice a wide and overlapping spread of the elastic modulus
(please note the logarithmic scale).
Correction for Osmolality
Changes in the osmotic pressure result in highly deformed
shapes, which lead to the formation of flattened discocytes
with a clear shrunk appearance. We came across artificially
deformed cells when we fixed RBCs of a patient with pyruvate
kinase deficiency (Figure 3A). The shrinkage of the RBCs
is proportional to the concentration of the glutaraldehyde
(Figures 3B,C) and although the osmolality increase of
glutaraldehyde solution scales linearly with its concentration,
there are severe differences between glutaraldehyde batches as
outlined in Figure 3B. While the change in osmolality might
not be relevant in certain cell types in terms of morphology
(Machado, 1967; Bone and Denton, 1971; Rasmussen, 1974),
for RBCs we observed that the osmolality is essential for shape
preservation (Figure 3C).
We are aware of the fact that glutaraldehyde may not
be osmotically active. It is an uncharged, rather hydrophobic
molecule that crosses the membrane, as it clearly reacts with
intracellular proteins with a fast kinetics. Whether an osmotic
effect could be present and relevant depends on the differential
permeability of the membrane to glutaraldehyde itself and to
water. Glutaraldehyde appears to act rapidly and to fix RBCs
within 1 s (Sutera and Mehrjardi, 1975). Water fluxes across the
RBC membrane are also fast owing to the presence of aquaporin.
So the two permeabilities may be seen as to be approximately
equivalent. Yet it is unknown if, and to what extent these
parameters change in the time frame of glutaraldehyde reacting
with the membrane, for instance affecting its own permeability
coefficient and/or that of aquaporin, not to mention all the
other protein-mediated transport systems of the RBC membrane.
In the literature it is also argued that the buffer osmolality
plays a more important role than the osmolality increase caused
by glutaraldehyde addition (Barnard, 1976; González-Aguilar,
1982). Despite of all this, we have nonetheless observed that
osmolality compensation by dilution of the buffer is essential
for the preservation of shapes within the spherocyte-discocyte-
echinocyte range, especially when glutaraldehyde is used in the
high concentration range.
For discocytes, as they are the most stable shape for the
cells, the range of tolerable osmolality is wide. Discocytes can
preserve their shape for osmolality values between 210 and
380 mosmol/kg H2O. Ideally 290 mosmol/kg H2O is the aimed
osmolality for most media, and it was also the osmolality
value that fixation solutions were corrected for within this
study. However, rare cell shapes are a lot more sensitive to
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FIGURE 3 | Osmolality changes induced by glutaraldehyde. (A) Patient
sample (pyruvate kinase deficiency) fixed in 1% glutaraldehyde without
correction for osmolarity (495 mosmol/kg H2O). The resulting dehydrated cells
have a flat aspect and borders and are spiky like in echinocytes. (B) Relation
between nominal glutaraldehyde concentration and osmolality in PBS for
three different batches of glutaraldehyde. (C) RBCs shapes are drastically
influenced by osmolality. Spherocytes can only preserve their shape for about
127 to 145 mosmol/kg H2O (a–c). Although for the uncorrected 1%
glutaraldehyde fixation (b), one would expect a shrinkage of the cell, we
observed a high percentage of lysis with only a few cells left. Discocytes (d–f)
can preserve their shape for osmolality values between 210 and
380 mosmol/kg H2O. 290 mosmol/kg H2O is the aimed osmolality for most
mediums and it was the osmolality value that fixation solutions were corrected
to be for this study. For the echinocytes (g–i) a more pronounced shrinkage
can be seen in uncorrected 1% glutaraldehyde solution (h). The detailed
osmolalities are (in mosmol/kg H2O) for (a): 131; (b): 214; (c): 122; (d): 291;
(e): 389; (f): 292; (g): 802; (h): 877; (i): 774. Please note that the indicated
glutaraldehyde concentrations in all panels are batch-specific and not of
general validity.
osmolality changes. For example; spherocytes can only preserve
their shape for about 127 to 145 mosmol/kg H2O, which is a
much narrower range.
Monomers and Polymers
In a glutaraldehyde solution monomers and polymers coexist
(compare Figure 1). Both monomers and polymers have
different “fixation properties.” In particular, the higher
efficiency in crosslinking due to monomers or polymers
is discussed controversially (Richards and Knowles, 1968;
Hardy et al., 1969; Robertson and Schultz, 1970; Gillett
and Gull, 1972). While preparation/purification to yield
pure monomeric and polymeric solutions requires a certain
preparation effort, the analysis of differences or variations
of cell ultrastructure in electron microscopy (Bessis, 1974)
goes far beyond the frame of this report. However, it is of
interest to evaluate the particular composition of glutaraldehyde,
which can be measured by UV-absorption spectroscopy
as indicated in Figure 4A depicting the large variety of
glutaraldehyde solutions used in our laboratories. The ratio
of absorbance between 280 nm (monomer, Figure 4B) and
235 nm (polymer) can be taken as the monomer-polymer
ratio (Figure 4C). Our results show indeed that glutaraldehyde
polymerization can vary between batches. Change over
time, in particular when stored at room temperature is the
most likely cause for the differing ratios. In addition and
independent of the polymerization, we found variations in
the concentration of different glutaraldehyde batches for
nominal equal concentrations as indicated by the optical density
of the monomer peak depicted in Figure 4B. Therefore, it
is important to document both, the monomer to polymer
ratio of glutaraldehyde as well as the peak of the monomer
concentration as a reference.
Handling Pitfalls
When RBCs are pipetted into a glutaraldehyde solution they
are believed to be fixed within 1 s (Sutera and Mehrjardi,
1975). This means that if the pipetting creates a considerable
flow (compare also Wiegmann et al., 2017), the cellular shape
adaptation to flow (Lanotte et al., 2016; Quint et al., 2017) is
also conserved, which is a deviation from RBC shape in stasis
(Figure 5) and must be regarded as an artifact. The cells marked
by red circles in Figure 5 include knizocytes (trilobes), a clear
indication for flow induced cell shape changes (Lanotte et al.,
2016). Gentle pipetting is compulsory when fixing with 1% or
higher glutaraldehyde concentrations. In addition a pre-dilution
in saline solution of the blood sample to a hematocrit of 5% or
lower proved to be helpful, due to a decrease in the viscosity of the
suspension (Eckmann et al., 2000) and thus a decrease in shear
stress on the cells.
In microfluidics, glutaraldehyde treated cells are often used
to test deformability-based cell sorting devices, as well as to
study flow of non-deformable particles (Holmes et al., 2014;
Tomaiuolo et al., 2015). One common problem that often occurs
while working with fixed cells is the increased sedimentation
rate due to higher density of cells. This disadvantage can be
improved upon by using a lower glutaraldehyde concentration
for fixation. The density of cells that have been fixed with
1% was measured to be 1.21 g/ml whereas the density for
0.1% fixed cells is 1.18 g/ml, while the average cell density
of living cells is 1.10 g/ml. We considered two possible
reasons that could explain the increase in density of cells
post-fixation: either the cross-linking caused a decrease in
the cell volume (cellular dehydration), or the binding of the
glutaraldehyde molecules on the cell increased the mass of
the cell. Since glutaraldehyde has molar density of 0.933 g/ml
(Zang et al., 2016), which is lower than both surrounding
medium and the healthy cell density (1.1 g/ml), the addition
of glutaraldehyde molecules to the cell membrane is unlikely to
increase the density of the cell. From the density measurements
Frontiers in Physiology | www.frontiersin.org 6 May 2019 | Volume 10 | Article 514
fphys-10-00514 May 10, 2019 Time: 14:45 # 7
Abay et al. Glutaraldehyde for Preservation of Erythrocytes
FIGURE 4 | Batch variations of glutaraldehyde. (A) Normalized absorption spectra of two different batches of glutaraldehyde in distilled water. The solid line shows
predominantly the monomere peak, whereas the highest band of the dashed line represents the polymers. (B) Comparison of the monomer absorption peak for 4
batches of glutaraldehyde with nominally the same concentration of 1% in distilled water. (C) Ratio between monomers and polymers derived from 1%
glutaraldehyde solutions in distilled water for 4 different batches of glutaraldehyde.
FIGURE 5 | Shear induced artifacts during glutaraldehyde fixation. (A) Representative fixation examples in 1% glutaraldehyde solution in dependence of the sample
preparation. (a) 100 µl of whole blood pipetted into a 1% glutaraldehyde solution; (b) 10 µl of whole blood pipetted into a 1% glutaraldehyde solution; (c) 100 µl of a
1:10 diluted blood suspension pipetted into a 1% glutaraldehyde solution. Circles indicate knizocytes and arrows otherwise deformed RBCs. (B) Representative
fixation examples of 5 µl whole blood in (a) 1% glutaraldehyde and (b) 0.1% glutaraldehyde. (C) Patient sample (pyruvate kinase deficiency) fixed in 1%
glutaraldehyde with cells showing shear induced artifacts as the knizocytes marked with circles. Please note that the indicated glutaraldehyde concentrations in all
panels are batch-specific and not of general validity.
we can calculate that 1% glutaraldehyde fixation results in
approximately 9% volume decrease, whereas 0.1% fixation
results in approximately 7%. A possibility to counterbalance
the increase in density is the adaptation of the density of
the suspension, e.g., by using OptiPrep (Stemcell Technologies,
Vancouver, BC, Canada).
Glutaraldehyde Induced Fluorescence
and Staining of Fixed Cells
Staining of fixed RBCs requires to consider both the possible
interference of hemoglobin with fluorescent dyes (Kaestner et al.,
2006) and the fluorescence induced by glutaraldehyde. Although
the autofluorescence of the glutaraldehyde itself is negligible it
Frontiers in Physiology | www.frontiersin.org 7 May 2019 | Volume 10 | Article 514
fphys-10-00514 May 10, 2019 Time: 14:45 # 8
Abay et al. Glutaraldehyde for Preservation of Erythrocytes
FIGURE 6 | Fluorescence induced by glutaraldehyde fixation. (A) Normalized excitation and fluorescence spectra of a RBC suspension fixed with 1%
glutaraldehyde. (B) Confocal images of RBC fixed with 1% glutaraldehyde before (left image) and after (right image) suspending the cells in trypan blue solution.
(C) Normalized absorption spectra of hemoglobin and trypan blue to spectrally judge fluorescence quenching. (D) 3D images of RBCs fixed with 1% glutaraldehyde.
Left image shows the autofluorescence based on the excitation wavelength of 561 nm (no excitation of CellMask). Right image shows the CellMask fluorescence of
the same cells excited with a wavelength of 647 nm (only residual glutaraldehyde induced fluorescence). The yellow circle marks a white blood cell. Please note that
the indicated glutaraldehyde concentrations in all panels are batch-specific and not of general validity.
forms fluorescent entities upon binding to peptides and proteins
(Lee et al., 2013).
To judge the fluorescence induced by glutaraldehyde, the
excitation and emission spectra of the glutaraldehyde fixed
RBCs is presented in Figure 6A. We present spectra of cell
suspensions fixed with 2 different batches of glutaraldehyde.
For the almost exclusive monomeric glutaraldehyde (batch
4 in Figure 4C), the induced fluorescence contains distinct
narrow bands (thin lines in Figure 6A), whereas the mixture of
monomers and polymers (batch 2 in Figure 4C) gives in addition
to the monomer band a wide band fluorescence background
(bold lines in Figure 6A), exceeding the range of the spectra
measured. This demonstrates that the induced fluorescence
can be a problem in immunofluorescence staining (see also
below), also considering the wide spectral range of the induced
fluorescence, in particular in the presence of glutaraldehyde
polymers. Especially when quantitative fluorescence intensity
measurements are required, it is crucial to take the glutaraldehyde
induced fluorescence into account. Therefore, we present a
previously described method to quench the fluorescence by
addition of trypan blue (Loike and Silverstein, 1983). Confocal
sections of glutaraldehyde fixed RBCs (excitation at 488 nm)
in the absence and presence of trypan blue are exemplified in
Figure 6B. Although the fluorescence signal is reduced, it could
not be completely excluded. To evaluate the putative effect of
trypan blue, the absorption spectrum is depicted in Figure 6C.
Additionally, the absorption spectrum of hemoglobin is plotted
in Figure 6C.
To evaluate the putative use of the glutaraldehyde induced
fluorescence for RBC imaging we present in Figure 6D 3D-
images of glutaraldehyde fixed and CellMask stained cells.
While the left image in Figure 6D predominantly presents
glutaraldehyde induced fluorescence, the right image depicts
mainly CellMask fluorescence. To highlight the special properties
of RBCs we choose an image that contains by chance a white
blood cell (marked with a yellow circle in Figure 6D).
To further illustrate the scenario of interaction between
glutaraldehyde and the staining of proteins of interest we
present two prominent examples of (i) a cytosolic protein and
(ii) a membrane protein. (i): We performed flow cytometric
measurements of living RBCs and fixed cells with different
concentrations of glutaraldehyde with and without additional
staining of the (cytosolic) hemoglobin F (Figure 7A). Induced
fluorescence is high at 1% glutaraldehyde but lower at decreased
concentrations. Furthermore, flow cytometry data reveal higher
fluorescence for samples kept in glutaraldehyde for longer time
(several hours, data not shown). Moreover, cells showed different
fluorescence intensities within the same sample, underlining
different glutaraldehyde binding amounts between individual
cells. This might reflect cell protein content, which varies between
cells, e.g., in dependence of RBC age (Kaestner and Minetti,
2017). Additionally, we observe the effect that long staining with
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FIGURE 7 | Staining of glutaraldehyde fixed samples. (A) Flow cytometric analysis of cord RBCs for the detection of cytosolic fetal hemoglobin F. Panels (a–e) are
plotted at the same scale as annotated in panel (a). (a): unstained control RBCs; (b): cord blood fixed with 0.05% glutaraldehyde; (c) cord blood fixed with 0.05%
glutaraldehyde and consecutively stained with an antibody against hemoglobin F; (d) cord blood fixed with 1% glutaraldehyde; (e): cord blood fixed with 1%
glutaraldehyde and consecutively stained with an antibody against hemoglobin F. (B) Eosin-5′-maleimide (EMA) staining of RBCs. (a): EMA staining of living cells
induces cell shape changes. (b): EMA staining of 0.1% glutaraldehyde fixed RBCs, the left image is excited at 488 nm, the excitation peak of EMA with only residual
glutaraldehyde induced fluorescence. The right image is excited at 647 nm where no EMA fluorescence is induced but the residual glutaraldehyde induced
fluorescence is sufficient to image RBCs. Both images reveal a very heterogeneous fluorescence, whereas the fluorescence intensity is inverted, i.e., cells with a high
EMA fluorescence show a low glutaraldehyde induced fluorescence and vice versa. (c): 0.1% glutaraldehyde fixation of EMA stained cells, the images are recorded
under the same conditions as in (b). The left image depicts a similar pattern as the living cells presented in (a), while the right image shows the glutaraldehyde
induced fluorescence. Please note that the indicated glutaraldehyde concentrations in all panels are batch-specific and not of general validity.
high (1%) concentrations of glutaraldehyde prevents binding
of the antibodies (Figures 7Aa–e). However, hemoglobin F
antibodies (FITC) can distinctively be identified in 0.05%
glutaraldehyde fixation. (ii): We imaged RBCs stained with EMA,
which binds to the amino group of Lys-430 on RBCs membrane
Band 3 protein and it is commonly used to estimate Band 3
protein abundance. Figure 7B compares images of living cells
(Figure 7Ba), EMA staining after 0.1% glutaraldehyde fixation
(Figure 7Bb) and fixation with 0.1% glutaraldehyde after EMA
staining (Figure 7Bc).
Also the choice of the particular dye might be influenced
by the glutaraldehyde. This statement goes beyond the obvious
spectral selection presented above. For illustration we tested
two types of cell membrane fluorescent staining dyes both on
living and fixed cells: PKH dyes proved to be reliable for RBC
in vivo staining for several weeks (Wang et al., 2013); CellMask
is a popular dye to stain RBC in vitro (Flormann et al., 2017).
While for living cells we observed a homogeneous membrane
staining, the dyes did not always show to be ideal on fixed cells.
PKH26 as well as PKH67 in particular resulted in the formation
of visible “filaments” forming at the cell membrane (Figure 8).
For CellMask we occasionally noticed the formation of small
accumulations of dye in certain fixed samples, when staining at
low concentrations. Such an inconsistent effect could be due to
the monomer/polymer ratio of the glutaraldehyde affecting the
crosslinking of cells.
Special Emphasis on Sickle Cell Disease
Since glutaraldehyde consumes oxygen during its reaction with
compounds (Johnson, 1987), we investigated if a glutaraldehyde
induced deoxygenation could cause hemoglobin crystallization
in sickle cell disease patients, transforming discocytes containing
oxygenated hemoglobin into sickle cells. To this end we fixed
oxygenated and deoxygenated RBCs of a sickle cell disease patient
with 1% of glutaraldehyde and performed scanning electron
microscopy (SEM). The resulting SEM images are presented
in Figure 9, clearly showing discocytes in oxygenated cells
(Figure 9A) and sickled cells in deoxygenated RBCs (Figure 9B)
of the same patient.
DISCUSSION
Fixation vs. Modulation of Stiffness
Previous literature gives different meanings to the concept of
“fixation”: conservation of cells (Nowakowski and Luckham,
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FIGURE 8 | Representative confocal 3D-images of membrane stained RBCs.
(A) and (B) show RBCs stained with PKH67, while (C) and (D) are stained
with CellMask deep red. (A) and (C) depict living RBCs, while (B) and (D)
contain cells fixed in 1% glutaraldehyde. The red arrows point to the filaments
formed in fixed RBCs stained with PKH67. Please note that the indicated
glutaraldehyde concentration in panels (B) and (D) are batch-specific and not
of general validity.
2002; Faivre et al., 2006; Karon et al., 2012) and regulation
of cellular rigidity (Guo et al., 2014; Tong and Caldwell,
1995). This study emphasizes the subtle difference between
the two concepts as presented in Figures 2A,B. Fixation of
cells with glutaraldehyde and increase in cellular stiffness are
two different pairs of shoes. Fixation can be thought of as
a binary state (all or none), whereas rigidity can be roughly
regulated at low glutaraldehyde concentrations, as shown by
ektacytometry (Figure 2B) and atomic force spectroscopy
(Figure 2C). However, for the latter application one should avoid
the term “fixation,” because instead of being fixed, cells are rather
more fragile (Figure 2A). Please note that the concentrations
of glutaraldehyde given in Figure 2 and in the results sections
can’t be regarded as general numbers, because the batch to batch
differences (Figure 4 and discussion below), probably highly
influenced by the ratio of monomers and polymers, have a
tremendous influence on the fixation properties. Furthermore,
glutaraldehyde appears to have a toxic effect on the cells for
0.0001 and 0.001% concentrations (Figure 2A), since they
exhibited more lysis than the control case (living cells). The
toxicity effect also can explain the increase of lysis from a
0.0001 to 0.001%.
Correction for Osmolality
Unlike some other types of cells, RBC morphology is highly
sensitive to several parameters, e.g., mechanical stress, pH
changes, addition of chemical agents and osmolality differences.
Because of such changes, RBC shapes are thoroughly studied
in blood diseases, where genetic mutations and/or impaired
cell functions affect cell shapes (Ponder, 1948; Delaunay, 2004;
FIGURE 9 | Scanning electron microscopy images of RBCs of a sickle cell
disease patient. (A) oxygenated cells fixed with 1% glutaraldehyde.
(B) deoxygenated RBCs (8 h in a hypoxic glove box with 0.2% PO2) of the
same sickle cell disease patient as in (A) also fixed with 1% glutaraldehyde.
Please note that the indicated glutaraldehyde concentrations in all panels are
batch-specific and not of general validity.
Diez-Silva et al., 2010; Fermo et al., 2017). This implies
that morphological analysis must be performed on reliable
samples. Cell fixation is an ideal step when working with rare
anemias, where patients’ samples often need to be investigated
in specialized laboratories and may be stored before the analysis
can be performed (Figure 3B). It is well known that RBC
shapes are sensitive to osmolality (Reinhart et al., 2015).
Adding 1% glutaraldehyde to a given solution increases the
osmolality by approximately 100 mosmol/kg H2O, which results
for physiological solutions in a relevant osmolality change of
approximately 30%. Even if fixation occurs within seconds, the
osmotic pressure difference allows water to flow in or out of
the cell, affecting the shape that will be fixed. Such a water
flow is also observed at higher glutaraldehyde concentrations,
where the increase in osmolality is proportionally higher while
fixation occurs faster (data not shown). Our results show that
each shape has a different tolerance to osmolality, spherocytes
being the most fragile and unstable shape (Figure 3A). Therefore
the evaluation of spherocytes underlines the importance of
osmolality correction in the fixative. If the osmolality is
particularly high, discocytes appear flattened and borders slightly
spiky, resembling echinocytes. Cells do not fully deform into
echinocytes probably because of the simultaneous crosslinking
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of glutaraldehyde while dehydration occurs. In the case of
discocytes, a judgment on fixed shape quality becomes generally
more difficult because the shape change is less evident and often
subjective to the observer. Therefore we see a need for automated
(unbiased) cell shape analysis algorithms. A visual inspection is
not enough for comparison with living cells, even in 3D imaging.
We can, however, mention that cells fixed in 1% corrected
glutaraldehyde resemble cells fixed in 0.1% glutaraldehyde, where
the osmotic imbalance after addition of glutaraldehyde to the
buffer is minimal (10 mosmol/kg H2O). Therefore we suggest
to verify the osmolality of the fixative solution before fixation
of any samples, particularly when dealing with patients that
display shape deformations, e.g., hereditary spherocytosis, sickle
cell disease or pyruvate kinase deficiency. Such diseased RBCs
might be more severly affected by environmental changes, like
osmolarity, than healthy discocytes.
Monomers and Polymers
Glutaraldehyde solutions are mixtures of monomers and
polymers as outlined in Figure 4. We did not investigate the
advantages and disadvantages of monomers and polymers for
the fixation of RBCs but this topic was previously discussed
controversially (Richards and Knowles, 1968; Hardy et al.,
1969; Robertson and Schultz, 1970). However, it is evident
that the ratio of monomers and polymers can vary between
different glutaraldehyde batches (Figure 4C), but the ratio can
easily be determined by UV-absorption spectroscopy. Previous
studies (Gillett and Gull, 1972; Rasmussen and Albrechtsen,
1974; Prentø, 1995) demonstrated that the storage temperature
of glutaraldehyde is among the most important parameters
for a stable preservation of the stock solution. Rasmussen
(1974) has tested different storage temperatures, concluding
that glutaraldehyde is most stable at −20◦C. The higher the
temperature, the faster the increase in polymer formation.
However, we point out that the uncontrolled formation of
polymers in the stock solution will affect the impact of
glutaraldehyde on osmolality, therefore making it necessary to
check the osmolality increase for every prepared solution before
applying osmolality correction.
Handling Pitfalls
As stated before, RBC morphology is affected by mechanical
stress, e.g., flow, to which RBCs adapt by changing their shapes
into hydrodynamic ones. Pipetting results in shear of RBCs,
which leads to the formation and fixation of flow shapes like
knizocytes (also referred to as trilobes) (Lanotte et al., 2016),
known to form at high shear rates (Figure 5). This highlights
that the speed of fixation is extremely fast, knowing that RBCs
in flow relax to the static shape in between 100 ms (Amirouche
et al., 2017) and 1 s (Braunmüller et al., 2011). We observed
knizocytes when fixing with 1% glutaraldehyde, but not when
fixing with lower concentrations, hinting to a slower fixation for
lower concentrations. Such distortions of the regular cell shape
can cause confusion when diseased RBCs are under investigation
(Figure 5C). To avoid the presence of flow induced shapes, we
found it is sufficient to dilute the blood sample to hematocrits of
5% in a solution of lower viscosity, e.g., PBS.
Staining of Fixed Cells
The fluorescence induced by glutaraldehyde is significant and
covers a wide range of wavelengths (Figures 6A, 7A), which
can be essential for the fluorescence measurement as exemplified
by the measurement of hemoglobin F in cord blood RBCs
using flow cytometry (Figure 7A) or by staining for Band
3 protein with EMA (Figure 7B). Although glutaraldehyde
induced fluorescence can in principle be used to image RBCs
(Figures 6B,D), the 3D-reconstruction reveals that fluorescence
intensity is limited and does not reach dedicated staining such as
CellMask staining (Figure 6D).
However, for fluorescent staining of membrane proteins that
do not require permeabilization of the RBCs we recommend to
first perform the membrane staining followed by the fixation.
Already the staining of Band 3 protein with EMA showed
severe inconsistencies that are likely to result from the fact that
glutaraldehyde also binds to amino groups, i.e., EMA needs to
compete with glutaraldehyde for putative binding sites (compare
Figure 7Bb). If this is already evident for the highly abundant
Band 3 protein, we expect even more severe effects for less
abundant proteins and their detection using antibodies.
According to the application needed, we recommend to
fix cells shortly if the autofluorescence signal is not desirable,
meaning few minutes, using low concentrations to avoid
higher autofluorescence than the signal coming from a specific
staining. Using monomeric glutaraldehyde, the autofluorescence
induced is in a narrower spectral range compared to polymeric
glutaraldehyde (Figure 6B). This results in a several fold reduced
autofluorescence at the popular laser line 488 nm, which is
also advantageous in respect to the absorption properties of
both hemoglobin and trypan blue (Figure 6C). Quenching tests
revealed trypan blue to be efficient, however, not completely
eliminating the signal (Figures 6C,D).
Membrane staining showed to be different between living
and fixed cells (Figure 8). While CellMask is toxic at high
concentrations on living cells, PKH dyes might not provide an
appropriate staining on fixed cells, even at low glutaraldehyde
concentrations. PKH consists of a fluorescent dye incorporated
in a long aliphatic chain that inserts into membrane lipids. Due
to the presence of glutaraldehyde crosslinking the membrane
proteins, it might be that PKH cannot be appropriately inserted
into the membrane, giving the formation of protrusions that
affect the quality of the staining (Figure 8B). CellMask is an
amphipathic molecule linked to a charged dye that can be used
both for the staining of living and fixed cells and resulted in
fact in a more efficient labeling of fixed cells with any tested
concentration of glutaraldehyde.
Sickle Cells
Generally, the effect of O2 consumption during glutaraldehyde
fixation is clearly visible in RBCs suspension, which upon fixation
become darker, as a consequence of methemoglobin formation
(Guillochon et al., 1986). However, up to 1% of glutaraldehyde
based fixation of sickle cells we could not detect any sickling
as outlined in Figure 9A and therefore we like to exclude
hemoglobin crystallization due to deoxygenation.
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CONCLUSION
In this section we will provide general recommendations to use
glutaraldehyde to fix or rigidify RBCs. Due to glutaraldehyde
variations between commercial providers, batch to batch
variations and conversions of glutaraldehyde during storage time,
these recommendations can hardly provide particular numbers
neither for the minimal glutaraldehyde concentration to fix or
rigidify the cells nor for the exact osmolality compensation.
Instead we recommend procedures to consider, with the aim to
ease glutaraldehyde use.
(i) We recommend to store glutaraldehyde at −20◦C in
aliquots to avoid unnecessary thawing of the whole
bottle for each use. Use these aliquots to prepare fresh
solutions before treating the cells. This allows a maximal
consistency within a series of measurements in a particular
laboratory over time.
(ii) The glutaraldehyde concentration to be used depends on
the purpose und needs to be determined for the particular
application and the particular glutaraldehyde batch. If
fixation is required, a quick control can be done by
washing the cells in distilled water prior to experiments.
Fully fixed, fully non-deformable cells, will not lyse or
have any morphological changes (test the supernatant
for hemoglobin). In general, concentrations between
0.05 and 0.1%, fix cells but do not require osmolality
compensation, limit the induced fluorescence as well as
the increase in the density of cells. However, attention
should be given, because fixation is not immediate but take
longer time. In contrast, concentrations of glutaraldehyde
around 1% require an osmotic compensation (see below)
and if induced fluorescence is not a hindering aspect,
1% glutaraldehyde provides a sound fixation and is
ideal for electron microscopy applications, where often
even higher percentages of glutaraldehyde are used as
these methods are physically more abrasive to the cells
compared to optical imaging. Additionally, we like to
mention the opportunity to set a fixation at a rather
low glutaraldehyde concentration, e.g., 0.05 – 0.1% and
increase the concentration in a second step to 1% to avoid
insufficient glutaraldehyde content.
(iii) We suggest to measure the osmolality of the glutaraldehyde
containing solution and correct it by diluting the
suspension buffer when fixing with 0.5% or higher
concentrations of glutaraldehyde.
(iv) It is recommended to check the monomer/polymer
ratio of the glutaraldehyde using a spectrometer and
provide this ratio in the publications as a way to help
interlaboratory comparability.
(v) It is necessary to consider the appropriate staining
dye and its concentration in relation to the induced
autofluorescence. If cell shapes are considered, the
autofluorescence is rather advantageous. Staining based
on the recognition of protein structures (antibodies) or
relying on the access to intracellular structures have
to be handled with care and should pre-tested on
glutaraldehyde treated positive controls to show the
feasibility. Trypan blue can be used to quench the
autofluorescence. Staining of membrane proteins (e.g.,
using dyes or cluster of differentiation antibodies) should
be performed prior to fixation.
ETHICS STATEMENT
The procedure is approved by the local ethics committee
(Approval No. 51/18) and was performed in accordance
with the Helsinki international ethical standards on
human experimentation.
AUTHOR CONTRIBUTIONS
All authors listed have made a substantial, direct and intellectual
contribution to the work, and approved it for publication.
FUNDING
The research leading to these results has received funding from
the European Framework “Horizon 2020” under grant agreement
number 675115 (RELEVANCE) and from the Volkswagen
Foundation (Az: 93839).
ACKNOWLEDGMENTS
We would like to thank Dr. Rob van Zwieten and Martijn
Veldthuis for assistance with the LoRRca, Matthias Jourdain
and Prof. Gregor Jung for assistance with the fluorescence
spectroscopy and Dr. Thomas Fischer for helpful comments and
a critical discussion of the manuscript.
REFERENCES
Aingaran, M., Zhang, R., Law, S. K., Peng, Z., Undisz, A., Meyer, E., et al. (2012).
Host cell deformability is linked to transmission in the human malaria parasite
Plasmodium falciparum. Cell. Microbiol. 14, 983–993. doi: 10.1111/j.1462-5822.
2012.01786.x
Amirouche, A., Ferrigno, R., and Faivre, M. (2017). Impact of channel
geometry on the discrimination of mechanically impaired red blood cells
in passive microfluidics. Proceedings 1:512. doi: 10.3390/proceedings104
0512
Barnard, T. (1976). An empirical relationship for the formulation
of glutaraldehyde-based fixatives. J. Ultrastruct. Res. 54,
478–786.
Bessis, M. (1974). Corpuscles. Berlin: Springer-Verlag.
Bone, Q., and Denton, E. J. (1971). The osmotic effects of electron
microscope fixatives. J. Cell Biol. 49, 571–581. doi: 10.1083/jcb.49.
3.571
Braunmüller, S., Schmid, L., and Franke, T. (2011). Dynamics of red blood cells
and vesicles in microchannels of oscillating width. J. Phys. Condens. Matter
23:184116. doi: 10.1088/0953-8984/23/18/184116
Frontiers in Physiology | www.frontiersin.org 12 May 2019 | Volume 10 | Article 514
fphys-10-00514 May 10, 2019 Time: 14:45 # 13
Abay et al. Glutaraldehyde for Preservation of Erythrocytes
Delaunay, J. (2004). The hereditary stomatocytoses: genetic disorders of the red cell
membrane permeability to monovalent cations. Semin. Hematol. 41, 165–172.
doi: 10.1053/j.seminhematol.2004.02.005
Diez-Silva, M., Dao, M., Han, J., Lim, C. T., and Suresh, S. (2010). Shape and
biomechanical characteristics of human red blood cells in health and disease.
MRS Bull. 35, 382–388. doi: 10.1557/mrs2010.571
Eckmann, D. M., Bowers, S., Stecker, M., and Cheung, A. T. (2000).
Hematocrit, volume expander, temperature, and shear rate effects on blood
viscosity. Anesth. Analg. 91, 539–545. doi: 10.1097/00000539-200009000-
00007
Faivre, M., Abkarian, M., Bickraj, K., and Stone, H. A. (2006). Geometrical
focusing of cells in a microfluidic device: an approach to separate blood plasma.
Biorheology 43, 147–159.
Fermo, E., Bogdanova, A., Petkova-Kirova, P., Zaninoni, A., Marcello, A. P.,
Makhro, A., et al. (2017). “GardosChannelopathy”: a variant of hereditary
Stomatocytosis with complex molecular regulation. Sci. Rep. 7:1744. doi: 10.
1038/s41598-017-01591-w
Flormann, D., Aouane, O., Kaestner, L., Ruloff, C., Misbah, C., Podgorski, T., et al.
(2017). The buckling instability of aggregating red blood cells. Sci. Rep. 7:7928.
doi: 10.1038/s41598-017-07634-6
Gillett, R., and Gull, K. (1972). Glutaraldehyde-its purity and stability. Histochemie
30, 162–167. doi: 10.1007/bf01444063
González-Aguilar, F. (1982). Cell volume preservation and the reflection coefficient
in chemical fixation. J. Ultrastruct. Res. 80, 354–362. doi: 10.1016/s0022-
5320(82)80048-8
Griffiths, G. (ed.) (1993). “Fine-structure preservation,” in Fine Structure
Immunocytochemistry, (Berlin: Springer), 9–25. doi: 10.1007/978-3-642-
77095-1_2
Guillochon, D., Esclade, L., and Thomas, D. (1986). Effect of glutaraldehyde
on haemoglobin: oxidation-reduction potentials and stability.
Biochem. Pharmacol. 35, 317–323. doi: 10.1016/0006-2952(86)
90532-0
Guo, Q., Duffy, S. P., Matthews, K., Santoso, A. T., Scott, M. D., and Ma, H. (2014).
Microfluidic analysis of red blood cell deformability. J. Biomech. 47, 1767–1776.
doi: 10.1016/j.jbiomech.2014.03.038
Hardy, P. M., Nicholls, A. C., and Rydon, H. N. (1969). The nature of
glutaraldehyde in aqueous solution. J. Chem. Soc. D 1969, 565–566. doi: 10.
1039/c29690000565
Hertz, L., Huisjes, R., Llaudet-Planas, E., Petkova-Kirova, P., Makhro, A.,
Danielczok, J. G., et al. (2017). Is increased intracellular calcium in red blood
cells a common component in the molecular mechanism causing anemia?
Front. Physiol. 8:673. doi: 10.3389/fphys.2017.00673
Holmes, D., Whyte, G., Bailey, J., Vergara-Irigaray, N., Ekpenyong, A., Guck,
J., et al. (2014). Separation of blood cells with differing deformability using
deterministic lateral displacement(†). Interface Focus 4:20140011. doi: 10.1098/
rsfs.2014.0011
Johnson, T. J. (1987). Glutaraldehyde fixation chemistry: oxygen-consuming
reactions. Eur. J. Cell Biol. 45, 160–169.
Kaestner, L., and Minetti, G. (2017). The potential of erythrocytes as cellular
aging models. Cell Death Differ. 24, 1475–1477. doi: 10.1038/cdd.201
7.100
Kaestner, L., Tabellion, W., Weiss, E., Bernhardt, I., and Lipp, P. (2006). Calcium
imaging of individual erythrocytes: problems and approaches. Cell Calcium 39,
13–19. doi: 10.1016/j.ceca.2005.09.004
Karon, B. S., van Buskirk, C. M., Jaben, E. A., Hoyer, J. D., and Thomas, D. D.
(2012). Temporal sequence of major biochemical events during blood bank
storage of packed red blood cells. Blood Transfus. 10, 453–461. doi: 10.2450/
2012.0099-11
Kawahara, J.-I., Ishikawa, K., Uchimaru, T., and Takaya, H. (1997). “Chemical
cross-linking by glutaraldehyde between amino groups: its mechanism and
effects,” in Polymer Modification, eds G. Swift, C. E. Carraher, and C. N. Bowman
(Boston, MA: Springer), 119–131. doi: 10.1007/978-1-4899-1477-4_11
Lanotte, L., Mauer, J., Mendez, S., Fedosov, D. A., Fromental, J.-M.,
Claveria, V., et al. (2016). Red cells’ dynamic morphologies govern
blood shear thinning under microcirculatory flow conditions. Proc.
Natl. Acad. Sci. U.S.A. 113, 13289–13294. doi: 10.1073/pnas.16080
74113
Lee, K., Choi, S., Yang, C., Wu, H.-C., and Yu, J. (2013). Autofluorescence
generation and elimination: a lesson from glutaraldehyde. Chem. Commun. 49,
3028–3030. doi: 10.1039/c3cc40799c
Loike, J. D., and Silverstein, S. C. (1983). A fluorescence quenching technique using
trypan blue to differentiate between attached and ingested glutaraldehyde-fixed
red blood cells in phagocytosing murine macrophages. J. Immunol. Methods 57,
373–379. doi: 10.1016/0022-1759(83)90097-2
Machado, A. B. (1967). Straight OsO4 versus glutaraldehyde-OsO4 in sequence
as fixatives for the granular vesicles in sympathetic axons of the rat
pineal body. Stain Technol. 42, 293–300. doi: 10.3109/1052029670911
5028
Makhro, A., Huisjes, R., Verhagen, L. P., Mañú Pereira, M. D. M., Llaudet-
Planas, E., Petkova-Kirova, P., et al. (2016). Red cell properties after different
modes of blood transportation. Front. Physiol. 7:288. doi: 10.3389/fphys.2016.
00288
Morel, F. M., Baker, R. F., and Wayland, H. (1971). Quantitation of human red
blood cell fixation by glutaraldehyde. J. Cell Biol. 48, 91–100. doi: 10.1083/jcb.
48.1.91
Nowakowski, R., and Luckham, P. (2002). Imaging the surface details of red blood
cells with atomic force microscopy. Surface Interface Anal. 33, 118–121. doi:
10.1002/sia.1174
Ponder, E. (1948). Hemolysis and Related Phenomena. New York, NY: Grune &
Stratton.
Prentø, P. (1995). Glutaraldehyde for electron microscopy: a practical investigation
of commercial glutaraldehydes and glutaraldehyde-storage conditions.
Histochem. J. 27, 906–913. doi: 10.1007/bf00173845
Quint, S., Christ, A. F., Guckenberger, A., Himbert, S., Kaestner, L., Gekle, S., et al.
(2017). 3D tomography of cells in micro-channels. Appl. Phys. Lett. 111:103701.
doi: 10.1063/1.4986392
Rasmussen, K. E. (1974). Fixation in aldehydes. A study on the influence
of the fixative, buffer, and osmolarity upon the fixation of the rat
retina. J. Ultrastruct. Res. 46, 87–102. doi: 10.1016/s0022-5320(74)80
024-9
Rasmussen, K.-E., and Albrechtsen, J. (1974). Glutaraldehyde. The influence of
pH, temperature, and buffering on the polymerization rate. Histochemistry 38,
19–26. doi: 10.1007/bf00490216
Reinhart, S. A., Schulzki, T., and Reinhart, W. H. (2015). Albumin
reverses the echinocytic shape transformation of stored erythrocytes.
Clin. Hemorheol. Microcirc. 60, 437–449. doi: 10.3233/CH-14
1899
Richards, F. M., and Knowles, J. R. (1968). Glutaraldehyde as a protein cross-
linking reagent. J. Mol. Biol. 37, 231–233. doi: 10.1016/0022-2836(68)
90086-7
Robertson, E. A., and Schultz, R. L. (1970). The impurities in commercial
glutaraldehyde and their effect on the fixation of brain. J. Ultrastruct. Res. 30,
275–287. doi: 10.1016/s0022-5320(70)80063-6
Squier, C. A., Hart, J. S., and Churchland, A. (1976). Changes in red blood cell
volume on fixation in glutaraldehyde solutions. Histochemistry 48, 7–16. doi:
10.1007/bf00489711
Suemori, S., Wada, H., Nakanishi, H., Tsujioka, T., Sugihara, T., and Tohyama, K.
(2015). Analysis of hereditary elliptocytosis with decreased binding of eosin-5-
maleimide to red blood cells. BioMed Res. Int. 2015:451861. doi: 10.1155/2015/
451861
Sutera, S. P., and Mehrjardi, M. H. (1975). Deformation and fragmentation of
human red blood cells in turbulent shear flow. Biophys. J. 15, 1–10. doi: 10.1016/
S0006-3495(75)85787-0
Tomaiuolo, G., Carciati, A., Caserta, S., and Guido, S. (2015). Blood linear
viscoelasticity by small amplitude oscillatory flow. Rheol. Acta 55, 485–495.
doi: 10.1007/s00397-015-0894-3
Tong, X., and Caldwell, K. D. (1995). Separation and characterization of red
blood cells with different membrane deformability using steric field-flow
fractionation. J. Chromatogr. B Biomed. Appl. 674, 39–47. doi: 10.1016/0378-
4347(95)00297-0
Wang, J., Wagner-Britz, L., Bogdanova, A., Ruppenthal, S., Wiesen, K., Kaiser,
E., et al. (2013). Morphologically homogeneous red blood cells present a
heterogeneous response to hormonal stimulation. PLoS One 8:e67697. doi:
10.1371/journal.pone.0067697
Frontiers in Physiology | www.frontiersin.org 13 May 2019 | Volume 10 | Article 514
fphys-10-00514 May 10, 2019 Time: 14:45 # 14
Abay et al. Glutaraldehyde for Preservation of Erythrocytes
Wiegmann, L., de Zélicourt, D. A., Speer, O., Muller, A., Goede, J. S., Seifert, B., et al.
(2017). Influence of standard laboratory procedures on measures of erythrocyte
damage. Front. Physiol. 8:731. doi: 10.3389/fphys.2017.00731
Zang, Q., Mansouri, K., Williams, A. J., Judson, R. S., Allen, D. G., Casey,
W. M., et al. (2016). In silico prediction of physicochemical properties of
environmental chemicals using molecular fingerprints and machine learning.
J. Chem. Inf. Model. 57, 36–49. doi: 10.1021/acs.jcim.6b00625
Zaninoni, A., Fermo, E., Vercellati, C., Consonni, D., Marcello, A. P., Zanella,
A., et al. (2018). Use of laser assisted optical rotational cell analyzer
(LoRRcaMaxSis) in the diagnosis of RBC membrane disorders, enzyme defects,
and congenital dyserythropoietic anemias: a monocentric study on 202 patients.
Front. Physiol. 9:451. doi: 10.3389/fphys.2018.00451
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2019 Abay, Simionato, Chachanidze, Bogdanova, Hertz, Bianchi,
van den Akker, von Lindern, Leonetti, Minetti, Wagner and Kaestner. This is an
open-access article distributed under the terms of the Creative Commons Attribution
License (CC BY). The use, distribution or reproduction in other forums is permitted,
provided the original author(s) and the copyright owner(s) are credited and that the
original publication in this journal is cited, in accordance with accepted academic
practice. No use, distribution or reproduction is permitted which does not comply
with these terms.
Frontiers in Physiology | www.frontiersin.org 14 May 2019 | Volume 10 | Article 514
